How a drug shortage is changing bladder cancer treatment - ABC listen For close to 50 years, a type of immunotherapy called Bacillus Calmette–Guerin (BCG) therapy has been used to treat early-stage bladder cancer. It’s still the regimen of choice, but a new study has i...

Great to see Prof Dickon Hayne talking to Norman Swan about the @anzuptrials.bsky.social #BCGMM study in the latest @abcaustralia.bsky.social Radio National Health Report @profiand.bsky.social #CancerAustralia www.abc.net.au/listen/progr...

Well done! The @anzuptrials.bsky.social #BCGMM trial has been presented at #ASCO25 showing BCG plus mitomycin a safe & effective alternative to BCG alone & the added benefit of requiring 40% fewer BCG doses. Congrats to Prof Dickon Hayne & team #NHMRCCTC @profiand.bsky.social #MSDAus #OmegaPharm

#BCGMM presented by Dickon Hayne at #ASCO25. Simple question, hard trial, needed a cooperative group like @anzuptrials.bsky.social #NHMRCTrialsCentre. Discussant John Sfakianos very enthusiastic, one of the most impactful #NMIBC trials he has seen, will change his practice. #BladderCancer #blcsm